Physician
Clearwater Investments INC Byrdstown Medical
Clearwater Investments INC Byrdstown Medical was paid $1.78M by Medicaid between Jan 2018 and Dec 2023, across 90 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoCLEARWATER INVESTMENTS INC BYRDSTOWN MEDICAL
BYRDSTOWN, TN 38549
BYRDSTOWN, TN 38549
33aNPI1679583801assigned 08/09/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.78M
24GClaims117,240
24DCodes billed90
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Family Medicine Physician providers in Tennessee
Rank by total paid#34 of 754
Median peer was paid$34K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,568 | $456K | |
| 2019 | 27,974 | $450K | |
| 2020 | 15,734 | $281K | |
| 2021 | 13,483 | $208K | |
| 2022 | 15,899 | $212K | |
| 2023 | 13,582 | $176K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 23,167 | 18,353 | $770K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 18,654 | 14,867 | $549K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.4% | 7,882 | 4,795 | $61K |
| 87428 | 2.3% | 982 | 871 | $41K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 1,641 | 1,244 | $40K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 3,552 | 2,911 | $34K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 528 | 462 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 9,848 | 8,142 | $25K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 497 | 444 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 2,557 | 2,118 | $22K |
| 87631 | <1% | 177 | 156 | $17K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,258 | 1,099 | $16K |
78 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 295 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 677 | $15K |
| 80053 | Comprehensive metabolic panel | <1% | 6,778 | $10K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 190 | $10K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 160 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,600 | $8K |
| 90670 | <1% | 466 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,023 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 765 | $7K |
| 80061 | Lipid panel | <1% | 2,625 | $5K |
| 83735 | <1% | 2,703 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 81 | $4K |
| 81001 | <1% | 3,753 | $4K | |
| 90461 | <1% | 853 | $4K | |
| 87807 | <1% | 494 | $4K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 958 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 847 | $3K |
| 80305 | <1% | 747 | $3K | |
| 99177 | <1% | 453 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 404 | $3K |
| 90674 | <1% | 180 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,387 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,140 | $2K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 457 | $2K |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 334 | $2K |
| 90710 | <1% | 14 | $1K | |
| 90633 | <1% | 172 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 112 | $1K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 122 | $752.83 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 45 | $721.96 |
| 99406 | <1% | 134 | $703.57 | |
| 99307 | <1% | 174 | $693.06 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 20 | $666.42 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 611 | $643.89 |
| 80050 | General health panel | <1% | 217 | $628.26 |
| 90723 | <1% | 62 | $596.96 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 21 | $583.87 |
| 84439 | <1% | 363 | $509.15 | |
| 74018 | <1% | 47 | $457.78 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 913 | $452.37 |
| 0011A | <1% | 18 | $433.88 | |
| 90688 | <1% | 89 | $363.29 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 54 | $361.88 |
| 83655 | <1% | 30 | $326.12 | |
| 90681 | <1% | 70 | $319.99 | |
| 85651 | <1% | 354 | $254.73 | |
| 99304 | <1% | 36 | $251.21 | |
| 85610 | <1% | 219 | $250.95 | |
| 93000 | <1% | 28 | $239.28 | |
| 90756 | <1% | 49 | $208.94 | |
| 90648 | <1% | 47 | $183.62 | |
| 99497 | <1% | 30 | $181.49 | |
| 74022 | <1% | 13 | $180.80 | |
| 90682 | <1% | 13 | $150.00 | |
| 90698 | <1% | 42 | $141.65 | |
| 84436 | <1% | 65 | $117.80 | |
| 72110 | <1% | 13 | $111.87 | |
| 90653 | <1% | 67 | $101.20 | |
| 90716 | <1% | 21 | $98.91 | |
| 86308 | <1% | 34 | $97.13 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 79 | $83.52 |
| 80051 | <1% | 34 | $80.71 | |
| 90707 | <1% | 19 | $59.00 | |
| 83721 | <1% | 41 | $55.24 | |
| 82565 | <1% | 26 | $50.71 | |
| 84479 | <1% | 76 | $47.68 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 105 | $41.14 |
| 86430 | <1% | 58 | $35.73 | |
| 80076 | <1% | 31 | $35.40 | |
| 90655 | <1% | 15 | $35.38 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $33.41 |
| 84550 | <1% | 61 | $28.60 | |
| 91301 | <1% | 28 | $0.04 | |
| 96160 | 0% | 15 | $0.00 | |
| 90694 | 0% | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 143 | $0.00 |
| 1101F | 0% | 34 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, DEEDEE (CREDENTIALING / SYSTEMS ADMIN)